Journal ArticleOPEN ACCESS

Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

Cutis (2022) 109(3) 148-149
DOI: 10.12788/cutis.0470
5Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.

Cite

CITATION STYLE

APA

Tao, J., Rosenfeld, D., Hsu, J., & Bhatia, A. (2022). Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine. Cutis, 109(3), 148–149. https://doi.org/10.12788/cutis.0470

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free